Intrasurgical plasmin enzyme in diabetic macular edema.

[1]  T. Nabeshima,et al.  Ultrastructure of internal limiting membrane removed during plasmin-assisted vitrectomy from eyes with diabetic macular edema. , 2004, Ophthalmology.

[2]  A. Kampik,et al.  Posterior vitreous detachment induced by microplasmin. , 2004, Investigative ophthalmology & visual science.

[3]  H. Yamashita,et al.  Early postoperative retinal thickness changes and complications after vitrectomy for diabetic macular edema. , 2003, American journal of ophthalmology.

[4]  M. Czajka,et al.  [Use of enzyme in vitreoretinal surgery]. , 2002, Klinika oczna.

[5]  S. Priglinger,et al.  Vitreoretinal morphology of plasmin-treated human eyes. , 2002, American journal of ophthalmology.

[6]  A. Kampik,et al.  Plasmin-assisted vitrectomy eliminates cortical vitreous remnants , 2002, Eye.

[7]  Xiaoxin Li,et al.  Posterior vitreous detachment with plasmin in the isolated human eye , 2002, Graefe's Archive for Clinical and Experimental Ophthalmology.

[8]  L. Hesse.  [Using enzymes in the posterior eye segment. Current status and future possibilities]. , 2001, Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft.

[9]  L. Hesse.  Einsatz von Enzymen im hinteren Augenabschnitt Derzeitiger Stand und zukünftige Möglichkeiten , 2001, Der Ophthalmologe.

[10]  George A. Williams,et al.  Autologous plasmin enzyme in the surgical management of diabetic retinopathy. , 2001, Ophthalmology.

[11]  A. Kampik,et al.  Indocyanine green-assisted peeling of the internal limiting membrane may cause retinal damage. , 2001, American journal of ophthalmology.

[12]  A. Kampik,et al.  Paracentral scotomata: a new finding after vitrectomy for idiopathic macular hole , 2001, The British journal of ophthalmology.

[13]  A. Kampik,et al.  Ultrastructure of the vitreoretinal interface following plasmin assisted vitrectomy , 2001, The British journal of ophthalmology.

[14]  M. Trese,et al.  A new approach to stage 3 macular holes. , 2000, Ophthalmology.

[15]  F. Kuhn,et al.  Internal limiting membrane removal in the management of full-thickness macular holes. , 2000, American journal of ophthalmology.

[16]  A. Kampik,et al.  RESOLUTION OF DIABETIC MACULAR EDEMA AFTER SURGICAL REMOVAL OF THE POSTERIOR HYALOID AND THE INNER LIMITING MEMBRANE , 2000, Retina.

[17]  M. Trese.  Enzymatic Vitreous Surgery , 2000, Seminars in ophthalmology.

[18]  G. Fanelli,et al.  Peribulbar anesthesia with either 0.75% ropivacaine or a 2% lidocaine and 0.5% bupivacaine mixture for vitreoretinal surgery: a double-blinded study. , 1999, Anesthesia and analgesia.

[19]  T. Hikichi,et al.  Posterior vitreous detachment induced by injection of plasmin and sulfur hexafluoride in the rabbit vitreous. , 1999, Retina.

[20]  M. Trese,et al.  Successful closure of traumatic macular holes. , 1999, Retina.

[21]  George A. Williams,et al.  Plasmin enzyme-assisted vitrectomy in traumatic pediatric macular holes. , 1998, Ophthalmology.

[22]  N. Tachi,et al.  Vitrectomy for diffuse macular edema in cases of diabetic retinopathy. , 1996, American journal of ophthalmology.

[23]  H. Flynn,et al.  Vitrectomy for diabetic macular edema associated with a thickened and taut posterior hyaloid membrane. , 1996, American journal of ophthalmology.

[24]  C. Azzolini,et al.  Posterior Empty Spaces during Vitreoretinal Surgery , 1996, European journal of ophthalmology.

[25]  George A. Williams,et al.  Pharmacologic induction of posterior vitreous detachment in the rabbit. , 1993, Archives of ophthalmology.

[26]  M. Blumenkranz,et al.  Vitrectomy for diabetic macular traction and edema associated with posterior hyaloidal traction. , 1992, Ophthalmology.

[27]  S. Russell,et al.  Distribution of glycoconjugates in the human retinal internal limiting membrane. , 1991, Investigative ophthalmology & visual science.

[28]  T. Ishibashi,et al.  Immunofluorescent studies of fibronectin and laminin in the human eye. , 1987, Investigative ophthalmology & visual science.

[29]  L. Liotta,et al.  Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane. , 1981, Cancer research.

[30]  F. Ry.  Vitreoretinal juncture; topographical variations. , 1972 .